Common use of Accredited Clause in Contracts

Accredited. This Supplement has been prepared by the Manager solely for the benefit of persons interested in the proposed sale of the Interests, and any reproduction of this Supplement, in whole or in part, or the divulgence of any of its contents, without the prior written consent of the Manager, is prohibited. This Supplement must be read in conjunction with Memorandum, the limited liability company operating agreement of the Company and the separate designation agreement establishing Fund 1 - Accredited (the “Series 1 Designation”), each as amended, restated, supplemented or otherwise modified from time to time, and the other agreements and documents referred to in this Supplement and the Memorandum. Mammoth Private Capital, LLC This supplement (the “Supplement”) describes the terms of Mammoth Private Capital, LLC – Health and Tech Fund Series 1 (d/b/a Mammoth Health and Tech Fund 1 – Accredited) (“Fund 1 - Accredited”), a segregated series of Mammoth Private Capital, LLC, a Delaware limited liability company organized in multiple segregated series (the “Company”), and the offering of membership interests in Fund 1 - Accredited (the “Interests”). This Supplement supplements the confidential private placement memorandum of the Company, dated April 16, 2021 (as amended or supplemented from time to time, the “Memorandum”). This Supplement provides information of relevance to prospective investors contemplating subscribing for Interests. The Memorandum and this Supplement should be reviewed carefully by any investor intending to subscribe for an Interest. All capitalized terms not otherwise defined herein shall have the meanings set forth in the Memorandum. Fund 1- Accredited was organized for the purpose of long-term capital appreciation and to pursue a venture capital strategy by investing in early- to mid-stage health science companies and technology companies.